BRIDGEWAY CAPITAL MANAGEMENT, LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 28 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$27,000
-34.1%
60,0000.0%0.00%
-100.0%
Q2 2019$41,000
-50.0%
60,0000.0%0.00%0.0%
Q1 2019$82,000
-60.0%
60,000
-40.0%
0.00%
-50.0%
Q3 2018$205,000
+51.9%
100,000
+100.0%
0.00%
+100.0%
Q2 2018$135,000
+132.8%
50,000
+100.0%
0.00%0.0%
Q1 2018$58,000
-31.0%
25,0000.0%0.00%0.0%
Q4 2017$84,000
-50.9%
25,000
-53.8%
0.00%
-50.0%
Q3 2017$171,000
+31.5%
54,1350.0%0.00%0.0%
Q2 2017$130,000
-36.0%
54,1350.0%0.00%0.0%
Q1 2017$203,000
+42.0%
54,135
+85.8%
0.00%0.0%
Q4 2016$143,000
-43.0%
29,135
-21.5%
0.00%
-50.0%
Q3 2016$251,000
+54.0%
37,1350.0%0.00%
+33.3%
Q2 2016$163,000
-37.3%
37,1350.0%0.00%
-25.0%
Q1 2016$260,000
-24.2%
37,1350.0%0.00%
-33.3%
Q4 2015$343,000
+19.5%
37,135
+26.6%
0.01%0.0%
Q3 2015$287,00029,3350.01%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 1,889,652$26,531,0001.20%
WALL STREET ASSOCIATES 250,000$3,510,0000.33%
QVT Financial LP 368,330$5,001,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 485,000$6,809,0000.22%
Perceptive Advisors 100,000$1,404,0000.11%
Visium Asset Management, LP 461,336$6,477,0000.10%
Opaleye Management Inc. 12,172$171,0000.08%
Candriam S.C.A. 125,000$1,755,0000.04%
Spark Investment Management LLC 13,300$186,0000.03%
Nicholas Investment Partners, LP 30,000$421,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders